基于出生体重、胎龄和体重增长的早产儿视网膜病变改良筛查标准
Postnatal Growth and ROP研究为2006至2012年美加29家医院7483例早产儿的回顾性多中心队列,开发结合出生体重、胎龄和体重增长的筛查标准。6条标准预测459/459例1型ROP(敏感度100%,95%CI 99.2%-100%),并减少需检查婴儿2269例(30.3%)。
要点
- 6条标准预测1型ROP敏感度100%(459/459,95%CI 99.2%-100%)。
- 预测治疗病例524/524(100%)和2型病例466/472(98.7%)。
- 需检查婴儿减少2269例(30.3%)。
核心结论
- 该队列研究提供循证筛查标准,经验证后可纳入ROP筛查指南以减少北美需检查婴儿数。
研究设计与样本
- Postnatal Growth and ROP研究为2006至2012年美加29家医院的回顾性多中心队列研究。
- 纳入7483例有已知ROP结局的早产儿,采用混合建模方法评估出生体重、胎龄、体重增长等多参数。
主要发现
- 7483例婴儿中位出生体重1099(SD 359)g,中位胎龄28周(范围22-35)。
- 6条标准预测1型ROP敏感度100%(459/459,95%CI 99.2%-100%)。
- 预测治疗病例524/524(100%)和2型病例466/472(98.7%)。
- 需检查婴儿减少2269例(30.3%)。
关键数值与推荐
- 符合以下任一标准者需检查:胎龄<28周;出生体重<1051 g;10-19日龄体重增长<120 g、20-29日龄<180 g或30-39日龄<170 g;或脑积水。
临床怎么用
- 该标准可用于识别需ROP检查的早产儿,经验证后可纳入筛查指南以减少检查数量。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Current retinopathy of prematurity (ROP) guidelines, which are based on studies of high-risk infants and expert opinion, have low specificity for disease requiring treatment. Postnatal weight gain-based models improve specificity but have been limited by complexity and small development cohorts, which results in model overfitting and resultant decreased sensitivity in validation studies. OBJECTIVE: To develop a birth weight (BW), gestational age (GA), and weight gain (WG) prediction model using data from a broad-risk cohort of premature infants. DESIGN, SETTING, AND PARTICIPANTS: The Postnatal Growth and ROP Study was a retrospective multicenter cohort study conducted in 29 hospitals in the United States and Canada from 2006 to 2012 that included 7483 premature infants at risk for ROP with a known ROP outcome. A hybrid modeling approach was used that combined BW/GA criteria, weight comparison with expected growth from infants without ROP, multiple growth-interval assessments, consideration of nonphysiological WG, and user-friendly screening criteria. Numerous BW/GA levels, postnatal age periods, time intervals, and WG percentile thresholds were evaluated to identify the most robust parameters. MAIN OUTCOME AND MEASURES: Sensitivity for Early Treatment of ROP Study type 1 ROP and potential reduction in infants who require examinations. RESULTS: Of 7483 infants, the median (SD) BW was 1099 (359) g, the median GA was 28 weeks (range, 22-35), 3575 (47.8%) were female, 3615 (48.4%) were white, 2310 (30.9%) were black, 233 (3.1%) were Asian, 93 (1.2%) were Pacific Islander, and 40 (0.5%) were American Indian/Alaskan Native. Infants who met any of 6 criteria would undergo examinations: (1) a GA of younger than 28 weeks; (2) a BW of less than 1051 g; a WG of less than 120 g, 180 g, or 170 g during ages 10 to 19, 20 to 29, or 30 to 39 days, respectively; or hydrocephalus. These criteria predicted 459 of 459 (100%) type 1 (sensitivity, 100%; 95% CI, 99.2%-100%), 524 of 524 (100%) treated, and 466 of 472 (98.7%) type 2 cases while reducing the number of infants who required examinations by 2269 (30.3%). CONCLUSIONS AND RELEVANCE: This cohort study, broadly representative of infants who are undergoing ROP examinations, provides evidence-based screening criteria. With validation, the Postnatal Growth and ROP Study criteria could be incorporated into ROP screening guidelines to reduce the number of infants who require examinations in North America.
引用
- Binenbaum G, Bell EF, Donohue P, et al. Development of Modified Screening Criteria for Retinopathy of Prematurity: Primary Results From the Postnatal Growth and Retinopathy of Prematurity Study. JAMA Ophthalmol. 2018. PMID: 30003216. doi:10.1001/jamaophthalmol.2018.2753
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。